SPOTLIGHT -
Mike Hollan is an assistant managing editor for Pharmaceutical Executive and Medical Device and Technology and can be reached at mhollan@mjhlifesciences.com.
Vera Whole Health Announces Launch of Value-Based Primary Care Center in Atlanta
This facility is the first of four facilities to be built in the area.
ArisGlobal Announces Second Life Sciences Generative AI Council Session
The meeting is scheduled for May in Switzerland.
Pfizer Asks FDA to Approve RSV Vaccine for Adults as Young as 18 Years Old
The vaccine is already approved for older adults.
Synaptogenix Increases Stake in PsyaBio
The move is part of Synaptogenix’s partnership with Cannasoul.
Myonex Acquires Saveway Compounding Pharmacy
The pharmacy will now operate as Saveway Compounding Pharmacy, a Myonex company.
Labcorp Announces Expansions to Oncology Portfolio
These expansions include a new product, along with improvements to existing products.
Blue Cross to Increase Reimbursements to Small, Independent Practices in Massachusetts
The move is intended to improve access to care at these critical sites.
QuantalX Joins FDA’s Total Life Cycle Advisory Program
FDA’s program will provide guidance to the development of the company’s Delphi-MD technology.
Nevada Health Link Announces AI Implementation
The technology will reportedly improve consumer engagement.
Anivive Presents First Anti-Fungal Vaccine at World Vaccine Congress
The vaccine can reportedly prevent infection from a fungal source that impacts both people and dogs.
CVS Health Announces New Offerings for Pharmacy Students
The two programs will be offered to students and CVS interns.
FDA Approves First Digital Therapeutic for Major Depressive Disorder
Otsuka and Click Therapeutics co-developed Rejoyn, a digital therapeutic for MDD.
Non-Gene Edited Therapeutics: Q&A with Jeffrey Erickson, Vice President of Business Development at Triumvira
Erickson discusses his work developing unique, targeted autologous and allogeneic T cell therapeutics.
Mark Cuban’s Cost Plus Drugs Partners with Price.com
The two company’s will provide consumers with a platform where they can compare drug prices.
The State of Genomic Medicines: Q&A with Demaris Mills
Mills is working in leadership in two roles, one of which puts her on the forefront of the genomic medicine movement.
Benchmarks and NC ONEcare Partner in North Carolina
The two organizations will work together to advocate for better health outcomes for children and families in North Carolina.
Mishe Announces Omnichannel Pharmacy Network
The network will work with DiRx and MakoRX.
Pfizer Makes Publicis New Global Creative Duties Partner
The news comes less than a year after Pfizer announced that IPG would handle this role.
Researchers Present First Study Using Biomimetic AI Digital Twins
The study used technology developed by a variety of companies, including RYLTI.
Adapting to Remote Workers and Services: Q&A with Rebecca Marquez, Director of Custom Research at PMMI
Marquez discusses the results of a recent survey about how elements of the industry are reacting to a post remote-work world.
Minnesota Bill Would Increase Access to Genetic Testing
The bill would remove financial for genetic testing determined to be clinically appropriate.
FDA Grants 501(k) to Two Avicenna.AI Products
Both products are designed to help radiologists.
CSL Behring and Takeda Discuss Advancing Clinical Development and the Future of Trials
The conversation took place during the Veeva R&D Summit in Boston.
Deerfield Agency Appoints Bill Veltre as Executive Vice President and Head of Media
Veltre will develop the company’s media and digital strategy.
Stakeholder Capitalism: Q&A with Meg Alexander, Chief Strategy Officer at Ovid Therapeutics (Part 2)
Alexander continues her conversation, touching on topics like disinformation and diversity in clinical trials.
The Regulatory Consequences of the Mifepristone Case: Q&A with Meg Alexander, Chief Strategy Officer at Ovid Therapeutics
Alexander discusses the broader implications the case could have on FDA's ability to regulate the industry.
AbbVie to Acquire Landos Biopharma
The move will bring Landos’ lead drug, NX-13, under AbbVie’s umbrella.
Eli Lilly Announces Shortage for Certain Insulin Formations in April
The shortage is due to a reported manufacturing interruption.
Medicare to Cover Wegovy for Certain Indications
The drug was recently cleared to treat cardiovascular risks, making it eligible for Medicare Part D.
CDC Releases Health Alert and Pushes for Increase in Measles Vaccinations
The agency released guidelines for vaccinations guidelines for children as young as 6 months old.